1348. Identification of GB-0669, a Novel S-2 Targeted Spike Monoclonal Antibody in Development for S...
1348. Identification of GB-0669, a Novel S-2 Targeted Spike Monoclonal Antibody in Development for SARS-CoV-2 Prophylaxis
About this item
Full title
Author / Creator
Borriello, Francesco , Marden, Grace , Li, Hongru , Carlin, Eric , Sharma, Geetika , Menzenski, Monica , Jecrois, Anne , Palovcak, Eugene , Lord, Dana , Tao, Jenhan , Grigoryan, Gevorg , Root, Adam , Hopson, Kristen , Hazuda, Daria , Van Epps, Heather A , Ramos, Alex , Joh, Nathan H , Russell, Pamela and Garlick, Joseph D
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
More information
Scope and Contents
Contents
Abstract
Background
The clinical benefit of anti-spike mAbs for prophylaxis and treatment of SARS-CoV-2 is now well established (Baum 2020, Loo 2022, Westendorf 2022, Jones 2021, Kreuzberger 2021, Cathcart 2021, Hirsch 2022, Shi 2020); However, the evolution of SARS CoV-2 due to immune pressure has compromised the utility of all previously ap...
Alternative Titles
Full title
1348. Identification of GB-0669, a Novel S-2 Targeted Spike Monoclonal Antibody in Development for SARS-CoV-2 Prophylaxis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1093_ofid_ofad500_1185
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1093_ofid_ofad500_1185
Other Identifiers
ISSN
2328-8957
E-ISSN
2328-8957
DOI
10.1093/ofid/ofad500.1185
